Therapeutics and Clinical Risk Management
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q2 | 54.6% | 0.730 | Q1 | 74.3% |
| 2024 | 2.2 | Q2 | 51.9% | 0.699 | Q1 | 73.5% |
| 2023 | 2.3 | Q2 | 77.3% | 0.752 | Q1 | 77.8% |
| 2022 | 2.8 | Q3 | 81.5% | 0.652 | Q1 | 74.6% |
| 2021 | 2.8 | Q3 | 78.7% | 0.598 | Q1 | 72.8% |
| 2020 | — | — | 0.719 | Q1 | 76.8% | |
| 2019 | — | — | 0.604 | Q1 | 72.8% | |
| 2018 | — | — | 0.725 | Q1 | 76.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1178-203X
ISSN
1176-6336
region
Pacific Region
coverage
2006-2026